Jan 15, 2021
There has been a dearth of options available to clinicians when it comes to the pharmacological management of methamphetamine use disorder. On this background, a group from the USA have conducted a multisite, double-blind, two-stage, placebo-controlled trial with the...
Jan 14, 2021
Recently published research from Italy was conducted to describe the characteristics of adverse drug events (ADEs) with a fatal outcome encountered in the ED setting, including the drugs involved, the frequency of the events and an estimate of the preventability of...
Jan 13, 2021
Remdesivir has been the focus of much attention in the context of the COVID-19 pandemic. A recent examination of the WHO VigiBase® has focused on Adverse Drug Events (ADEs) amongst COVID-19 patients. 1086 ADEs were reported from the 439 individual case reports up to...
Jan 11, 2021
Bisphosphonates are widely used because of their effectiveness in reducing hip and osteoporotic fractures, but there have been concerns about atypical femur fractures. In study of women 50 years of age or older who were receiving bisphosphonates, researchers examined...
Jan 11, 2021
The merits and drawbacks of so-called “polypills” continue to be debated. Researchers have recently assessed the effects of this approach using a multi-component strategy that included a statin, antihypertensives and aspirin to reduce the risk of...
